Johnson & Johnson (JNJ)

175.50
-3.32(-1.86%)
Pre Market
174.67
-0.83(-0.47%)
- Real-time Data
  • Volume:
    8,548,933
  • Day's Range:
    175.17 - 179.37
  • 52 wk Range:
    155.72 - 186.69

JNJ Overview

Prev. Close
178.82
Day's Range
175.17-179.37
Revenue
-
Open
178.84
52 wk Range
155.72-186.69
EPS
7.42
Volume
8,548,933
Market Cap
461.81B
Dividend (Yield)
4.52
(2.58%)
Average Volume (3m)
7,767,067
P/E Ratio
23.64
Beta
0.66
1-Year Change
2.96%
Shares Outstanding
2,631,401,804
Next Earnings Date
18 Jul 2022
What is your sentiment on J&J?
or
Market is currently closed. Voting is open during market hours.

Johnson & Johnson News

Johnson & Johnson Analysis

Johnson & Johnson Company Profile

Johnson & Johnson Company Profile

Employees
141700

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Consumer Health segment offers baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company’s Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellSellStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy